FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2025
Back to search
Official data from USPTO
LUNGCLEAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LUNGCLEAR
ST13
US500000079366536Class
5, 10, 44
Filing
79366536
Registration
7477128
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10, 44
Filing date
01/18/2023
Registration date
08/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/20/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
SG
Examiner
CANTOR, JILLIAN REDDING
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
MIRXES PTE. LTD.
Representatives
Joseph G. Chu JCIP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical and veterinary use or purposes; Medical diagnostic reactants for medical and veterinary diagnosis of diseases; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical purposes; Biological indicators for medical diagnosisfor detecting and diagnosing cancer; veterinary diagnostic reagents; Diagnostic reagents in kit form for conducting molecular biology assays for medical and veterinary purposes; Diagnostic reagents for medical and veterinary purposes; Diagnostic reagents for use in diagnostic tests for medical and veterinary purposes; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; Medical diagnostic assays that test for genetic anomalies for medical use; Diagnostic preparations for medical use; Biochemical preparations for diagnostic use for detecting and diagnosing cancer; Diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use in the medical field; Test reagents for medical diagnosisdisease testing; diagnostic biomarker reagents for medical purposes; Chemical preparations for diagnostic medical purposesfor detecting and diagnosing cancer; Chemical preparations for use in medical diagnosticsnucleic acid analysis; Chemical preparations for detecting genetic and epigenetic predispositions for medical purposes; Medical diagnostic reagents for analysis of body fluids; Synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical usefor detecting and diagnosing cancer; nucleic acid amplification reagents for medical use
Class 10
Medical diagnostic apparatus for detecting and diagnosing cancer; Medical diagnostic instruments for analysis of body fluids; Biomedical testing apparatus for RNADNA and protein biomarkers testing; Medical diagnostics instruments in the nature of apparatus for testing RNADNA and protein biomarkers; medical instruments for infectious disease testing; Medical diagnostic testing apparatus for sale in kit form for testing RNADNA and protein biomarkers for diagnosing and detecting cancer; Medical diagnostic apparatus for testing RNADNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic in-vitro diagnostic testing apparatus for medical use for diagnosing and detecting cancer; Medical diagnostic testing apparatus for use in molecular biology procedurestesting DNARNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic apparatus for blood tests for medical use
Class 44
Medical diagnostic servicestesting and analysis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; Medical servicesnucleic acid analysis for cancer diagnosis and prognosis; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; genetic testing of animals for diagnostic or treatment purposes; medical laboratory services related to the treatment of patients; Medical advisory services in the field of oncological diseases; medical analysis for the diagnosis and treatment of persons; Medical serviceshealth risk assessment surveys; health-care services for treating and detecting cancer; genetic testing for medical purposes; Medical servicesnucleic acid screening for medical purposes; Medical analysis services for diagnosing and detecting cancer; medical screening; Health screening services in the field of cancer
Publications
History of USPTO decisions and trademark events.
22 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/10/2025
FIMP
FINAL DISPOSITION PROCESSED
02/10/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/20/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/20/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2024
RFNT
REFUSAL PROCESSED BY IB
11/22/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/27/2023
RFRR
REFUSAL PROCESSED BY MPU
10/27/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/20/2023
CNRT
NON-FINAL ACTION WRITTEN
10/19/2023
DOCK
ASSIGNED TO EXAMINER
10/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/31/2023
Continuous trademark protection
Get notified about every new filing that threatens LUNGCLEAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.